Lotte Biologics
Incheon, KR · Syracuse, NY
Compare Biologics CDMOs in Asia
Compare Biologics CDMOs in South Korea
Compare AAV CDMOs in Asia
Compare AAV CDMOs in South Korea
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
81.6
Signal Score
✓ FDA Inspections (2)
○ Clinical Trials
○ SEC Filings
✓ Press (20)
○ EMA GMP
○ MHRA GMP
Quick Facts: Lotte Biologics
- Signal Score
- 81.6/100 (as of 2026-10-29)
- Quality Compliance
- 100.0/100
- Headquarters
- Incheon, KR · Syracuse, NY
- Modalities
- Biologics, AAV
- Active Programs
- No ClinicalTrials.gov matches confirmed — 3 partnership signals in press (announcements, not verified)
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Lotte Biologics
Korean conglomerate entering biologics CDMO. $1.6B investment.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
FDA Inspections2 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2026-09-18)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 3 partnership announcements found in press monitoring.
Programs
— no verified data
Sponsors— no verified data
ModalitiesBiologics, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Partnership Signals (from press monitoring)
Company announcements, not verified evidence.
Financial Stability
68.0
Parent company: Lotte Group
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Lotte Group
Financial assessment: 68.0/100
Capacity
63.0
2 manufacturing sites
Sites: Incheon, South Korea, Syracuse, NY
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
Press Signals20 articles (not scored)
2 manufacturing sites
Lotte Biologics FDA Inspection History
2026-09
2024-09
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2026-09-18 |
LOTTE Biologics USA, LLC
East Syracuse, New York
Facility-linked
|
Drug Quality Assurance | Not posted | No Action Indicated (NAI) |
| 2024-09-19 |
Lotte Biologics USA, LLC
East Syracuse, New York
Facility-linked
|
Drug Quality Assurance | Not posted | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
Japan-accredited overseas site (PMDA)
biologics, general (non-sterile) · 1 site
- East Syracuse, United States · Lotte Biologics USA, LLC — biologics, general (non-sterile) · valid to Dec 31, 2027
PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)
Hiring Activity 8 open roles Beta
From public job postings on Lotte Biologics' careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
8
open roles
4
in manufacturing, quality, PD/MSAT, engineering or regulatory (50%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 0 new postings, 0 taken down.
By function
By site
Syracuse, NY
profile site
2 mfg/ops · 2 eng. · 3 other 7
2 mfg/ops · 2 eng. · 3 other 7
California, Washington, Oregon, Nevada, or Arizona
· 1 other 1
· 1 other 1
Modality words in job titles
Biologics (cell culture, USP/DSP)1
Notable roles
Associate Director, Procurement
Senior operations / quality role · Syracuse, NY
Latest postings
Sr. Automation Controls Engineer - Platform Engineering
Engineering & facilities · Syracuse, NY · posted Nov 17, 2026
Director, US Business Development & Sales (Western US Territory)
Commercial, BD & client projects · California, Washington, Oregon,... · posted Nov 16, 2026
Director, IT
Other (finance, HR, IT, other) · Syracuse, NY · posted Nov 5, 2026
Bioprocess Associate I (Downstream) - Nights
Manufacturing & operations · Syracuse, NY · posted Nov 2, 2026
Associate Director, Procurement
Manufacturing & operations · Syracuse, NY · posted Oct 28, 2026
HR Associate III (Payroll & Benefits)
Other (finance, HR, IT, other) · Syracuse, NY · posted Oct 23, 2026
EHS Manager
Other (finance, HR, IT, other) · Syracuse, NY · posted Aug 21, 2026
Senior Engineer, Bioconjugation Operations
Engineering & facilities · Syracuse, NY · posted Mar 27, 2026
Coverage: counted from Lotte Biologics' own careers board.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
job-boards.greenhouse.io
· Checked Nov 20, 2026 · Tracking since Oct 26, 2026
Company Signals 20 articles
Company announcements, not verified evidence. They do not change any score.
Rakuten Cancer Drug Data Boosts Lotte Biologics Outlook - Seoul Economic Daily
Rakuten Cancer Drug Data Boosts Lotte Biologics Outlook Seoul Economic Daily
Lotte Biologics expands US manufacturing partnership with Alvotech - The Korea Herald
Lotte Biologics expands US manufacturing partnership with Alvotech The Korea Herald
Lotte Biologics to manufacture Alvotech antibody biosimilars at Syracuse plant - Korea Biomedical Review
Lotte Biologics to manufacture Alvotech antibody biosimilars at Syracuse plant Korea Biomedical Review
Lotte Biologics partners with Alvotech to make biosimilars in New York - Chosunbiz
Lotte Biologics partners with Alvotech to make biosimilars in New York Chosunbiz
Lotte Biologics Wins Alvotech Biosimilar Order, Expands U.S. Syracuse Output - Seoul Economic Daily
Lotte Biologics Wins Alvotech Biosimilar Order, Expands U.S. Syracuse Output Seoul Economic Daily
Lotte Biologics announced on the 7th that it has signed a production order contract with global bios.. - 매일경제
Lotte Biologics announced on the 7th that it has signed a production order contract with global bios.. 매일경제
Alvotech And Lotte Biologics Announce US-Based Manufacturing Agreement To Increase Global Supply - TradingView
Alvotech And Lotte Biologics Announce US-Based Manufacturing Agreement To Increase Global Supply TradingView
Lotte Biologics Wins Contract to Manufacture Alvotech Biosimilar Drug Substance - BigGo Finance
Lotte Biologics Wins Contract to Manufacture Alvotech Biosimilar Drug Substance BigGo Finance
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition - MSN
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition MSN
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition - MSN
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate - MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate - MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate - MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate - MSN
Lotte Biologics inks agreement with Ottimo Pharma on antibody drug candidate MSN
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition - MSN
Lotte Group chief makes first inspection tour of U.S. bio campus since 2023 acquisition MSN
Lotte Biologics to showcase SoluFlex Link ADC platform at AACR 2026 - koreabiomed.com
Lotte Biologics to showcase SoluFlex Link ADC platform at AACR 2026 koreabiomed.com
LOTTE Biologics, Ottimo Pharma Sign Antibody Manufacturing Contract - Contract Pharma
LOTTE Biologics, Ottimo Pharma Sign Antibody Manufacturing Contract Contract Pharma
LOTTE Biologics Secures Partnership with a Japan-Based Global Pharmaceutical Companyobal Pharmaceutical Company - businesskorea.co.kr
LOTTE Biologics Secures Partnership with a Japan-Based Global Pharmaceutical Company Businesskorea
Lotte Biologics Signs Contract Development and Manufacturing Agreement for Anticancer Drug with Japanese Pharmaceutical Company - 아시아경제
Lotte Biologics Signs Contract Development and Manufacturing Agreement for Anticancer Drug with Japanese Pharmaceutical Company 아시아경제
Lotte Biologics secures Japan CDMO deal to advance cancer drug development - CHOSUNBIZ - Chosunbiz
Lotte Biologics secures Japan CDMO deal to advance cancer drug development - CHOSUNBIZ Chosunbiz
Frequently Asked Questions About Lotte Biologics
How many FDA inspections does Lotte Biologics have on record?
CDMO Signal tracks 2 FDA inspections for Lotte Biologics, sourced from the FDA inspection database. See the full inspection history above.
Has Lotte Biologics received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Lotte Biologics.
What is Lotte Biologics's CDMO Signal Score?
Lotte Biologics has a Signal Score of 82/100, based on quality, operations, financial stability, and capacity data.
Evaluating Lotte Biologics for a manufacturing program?
Use the free AI matchmaker to compare Lotte Biologics against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
FUJIFILM Diosynth Biotechnologies
Research Triangle, NC · Holly Springs, NC · Hillerod, DK
Signal Score: 86.7
AAV, mRNA/LNP, Biologics, mRNA, Microbial Fermentation, Recombinant Protein
Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
BioReliance (Merck)
Glasgow, UK · Rockville, MD
Signal Score: 80.3
AAV, Lentiviral, Biologics
Northway Biotech
Vilnius, LT; Waltham (MA), USA
Signal Score: 80.8
Biologics, mAbs, Recombinant proteins, pDNA, AAV, Viral vectors, Gene Therapy
ProBioGen
Berlin, DE
Signal Score: 78.1
AAV, Lentiviral, Biologics
Compare Lotte Biologics with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.